Pan Liu1, Bradley C Taber-Thomas2, Xiaoxue Fu2, Koraly E Pérez-Edgar2. 1. Child Study Center, The Pennsylvania State University, University Park, State College. Electronic address: pliu261@gmail.com. 2. Child Study Center, The Pennsylvania State University, University Park, State College.
Abstract
OBJECTIVE:Children with behavioral inhibition, a temperament characterized by biologically based hypervigilance to novelty and social withdrawal, are at high risk for developing anxiety. This study examined the effect of a novel attention training protocol, attention bias modification (ABM), on symptomatic, behavioral, and neural risk markers in children with behavioral inhibition. METHOD: Nine- to 12-year-old typically developing children identified as having behavioral inhibition (N = 84) were assigned to a 4-session active ABM training (n = 43) or placebo protocol (n = 41) using a double-blinded, randomized, controlled trial approach. Anxiety symptoms (Diagnostic Interview Schedule for Children-Fourth Edition), attention bias (AB; measured by a dot-probe task; AB = incongruent reaction time - congruent reaction time), and AB-related neural activation (measured by functional magnetic resonance imaging activation for the incongruent > congruent contrast in the dot-probe task) were assessed before and after the training sessions. RESULTS: Results showed that active ABM (n = 40) significantly alleviated participants' symptoms of separation anxiety, but not social anxiety, compared with the placebo task (n = 40); ABM did not modify behavioral AB scores in the dot-probe task; and at the neural level, active ABM (n = 15) significantly decreased amygdala and insula activation and increased activation in the ventrolateral prefrontal cortex compared with placebo (n = 19). CONCLUSION: These findings provide important evidence for ABM as a potentially effective protective tool for temperamentally at-risk children in a developmental window before the emergence of clinical disorder and open to prevention and intervention. Clinical trial registration information-Attention and Social Behavior in Children (BRAINS); http://clinicaltrials.gov/; NCT02401282.
RCT Entities:
OBJECTIVE:Children with behavioral inhibition, a temperament characterized by biologically based hypervigilance to novelty and social withdrawal, are at high risk for developing anxiety. This study examined the effect of a novel attention training protocol, attention bias modification (ABM), on symptomatic, behavioral, and neural risk markers in children with behavioral inhibition. METHOD: Nine- to 12-year-old typically developing children identified as having behavioral inhibition (N = 84) were assigned to a 4-session active ABM training (n = 43) or placebo protocol (n = 41) using a double-blinded, randomized, controlled trial approach. Anxiety symptoms (Diagnostic Interview Schedule for Children-Fourth Edition), attention bias (AB; measured by a dot-probe task; AB = incongruent reaction time - congruent reaction time), and AB-related neural activation (measured by functional magnetic resonance imaging activation for the incongruent > congruent contrast in the dot-probe task) were assessed before and after the training sessions. RESULTS: Results showed that active ABM (n = 40) significantly alleviated participants' symptoms of separation anxiety, but not social anxiety, compared with the placebo task (n = 40); ABM did not modify behavioral AB scores in the dot-probe task; and at the neural level, active ABM (n = 15) significantly decreased amygdala and insula activation and increased activation in the ventrolateral prefrontal cortex compared with placebo (n = 19). CONCLUSION: These findings provide important evidence for ABM as a potentially effective protective tool for temperamentally at-risk children in a developmental window before the emergence of clinical disorder and open to prevention and intervention. Clinical trial registration information-Attention and Social Behavior in Children (BRAINS); http://clinicaltrials.gov/; NCT02401282.
Authors: N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot Journal: Neuroimage Date: 2002-01 Impact factor: 6.556
Authors: Lauren K White; Kathryn A Degnan; Heather A Henderson; Koraly Pérez-Edgar; Olga L Walker; Tomer Shechner; Ellen Leibenluft; Yair Bar-Haim; Daniel S Pine; Nathan A Fox Journal: Child Dev Date: 2017-01
Authors: Thomas L Rodebaugh; Rachel B Scullin; Julia K Langer; David J Dixon; Jonathan D Huppert; Amit Bernstein; Ariel Zvielli; Eric J Lenze Journal: J Abnorm Psychol Date: 2016-06-20
Authors: Koraly Pérez-Edgar; Bethany C Reeb-Sutherland; Jennifer Martin McDermott; Lauren K White; Heather A Henderson; Kathryn A Degnan; Amie A Hane; Daniel S Pine; Nathan A Fox Journal: J Abnorm Child Psychol Date: 2011-08
Authors: Yuko Hakamata; Shmuel Lissek; Yair Bar-Haim; Jennifer C Britton; Nathan A Fox; Ellen Leibenluft; Monique Ernst; Daniel S Pine Journal: Biol Psychiatry Date: 2010-12-01 Impact factor: 13.382
Authors: Charles T Taylor; Robin L Aupperle; Taru Flagan; Alan N Simmons; Nader Amir; Murray B Stein; Martin P Paulus Journal: Soc Cogn Affect Neurosci Date: 2013-08-09 Impact factor: 3.436